News & Articles

Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds

The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases

Dr. Chia-Lin Wei, Professor of Genome Sciences at University of Washington, shares how to unlock DNA methylation insights for neuroscience and cancer research

Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress

Researchers save time, effort, and precious samples with round-the-lab access to ultra-pure water with precise volume control

As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease

A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival

Laboratory water quality is often overlooked but plays a pivotal role in ensuring accuracy, compliance, and reproducibility

Hear how researchers have discovered a new cellular mechanism that controls the stability of messenger RNA (mRNA) in cells

New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow

1 in 3 Phase II trials were terminated in 2024

The UG 100 offers a cost-effective and extremely low-error sequencing profile

Vote for the product that has made the most difference to your lab for the chance to win a $100 Amazon Gift Card (or equivalent currency)

By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable

Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.

Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine

New test format enhances commercialisation potential

Successful project delivery of Optimer binders with proven function as vaccine adjuvants

Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency

Dr. Murakami discusses the molecular tools enabling the pursuit of precision medicine